After a year-long voluntary moratorium to discuss regulations and safety measures, scientists are set to resume controversial H5N1 research.
Advertisement
The Scientist
Most Recent
Tumor cells rapidly divide by usurping a metabolic trick from normal cell development.
Women have come a long way, but roadblocks remain
Long-term, life, and disability insurers may still be able to deny coverage to patients with a genetic disease, under current nondiscrimination legislation.
The US Food and Drug Administration approves the first flu vaccine made from recombinant proteins rather than a weakened virus.
Fecal transplants outcompeted traditional antibiotics at curing a deadly intestinal infection.
People carrying a certain gene variant that dictates fresh underarms are less likely to wear antiperspirant.
The black smoky emission is nearly as important as carbon dioxide in driving global warming.
A US federal advisory committee finds that climate change is already impacting the country, and that it’s not about to stop.
Scientists use virus-free gene therapy on patient-derived stem cells to repair spinal muscular atrophy in mice.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
